A Behavioral Intervention for Depression and Chronic Pain in Primary Care (Relief-Hybrid)
NCT ID: NCT04290845
Last Updated: 2023-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2023-02-28
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To address this need, Relief-Hybrid was created. Subjects are randomized to either the Relief-Hybrid intervention or to Referral to Mental Health/Usual Care. Subjects in both arms will complete research assessments at 6, 9, and 12 weeks. Subjects in the Relief-Hybrid arm will receive 5 weekly sessions with the study therapist (licensed social workers, LCSWs) and 4 self-administered, mobile technology-assisted sessions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Behavioral Intervention for Depression and Chronic Pain in Primary Care
NCT03265210
A Community-Based Chronic Pain Self-Management Program in West Virginia
NCT03582683
Integrative Medicine Group Visits: A Patient-Centered Approach to Reducing Chronic Pain and Depression
NCT02262377
The Management of Work-Disability Associated With Co-Morbid Pain and Depression: A Feasibility Study
NCT05174429
A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults
NCT06671925
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Relief-Hybrid
Relief-Hybrid relies on a neurobiological model to simplify its behavioral targets and uses mobile technology to augment its interventions. Relief was co-developed with our primary care partners with the goal to be usable by non-physician clinicians of primary care offices eligible to provide billable services.
Relief-Hybrid
A 9-week behavioral intervention for primary care patients designed to reduce depression and pain-related disability.
Referral to Mental Health/Usual Care
Continuation of medical attention and treatment provided by physicians and other medical professionals at the primary care practice. Referral for mental health based on clinical indication. Participants receive an educational booklet on pain.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Relief-Hybrid
A 9-week behavioral intervention for primary care patients designed to reduce depression and pain-related disability.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* PHQ-9 score greater or equal to 10
* Chronic pain (non-cancer related, most days over the past 3 months)
* Capacity to consent
Exclusion Criteria
* Montreal Cognitive Assessment (MoCA) \< 24
* Active suicidal ideation (MADRS item #10 greater or equal to 4
* Severe or life-threatening medical illness
* Patients on psychotropics, opioids or benzodiazepines will be included if they do not meet DSM-5 criteria for opioid, anxiolytics or other substance abuse disorders
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dimitris Kiosses, PhD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Weill Cornell Internal Medical Associates (WCIMA)
New York, New York, United States
Iris Cantor Men's and Women's Health Centers
New York, New York, United States
Irving Sherwood Wright Center
New York, New York, United States
Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine
White Plains, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-10020967
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.